As NO deficiency is one of the pathogenetic mechanisms underlying kidney disease [16,17], two amino acids, l-arginine (the substrate of NOS) and l-citrulline (a precursor to l-arginine) in the NO pathway, have been studied to ameliorate kidney disease [102,103,104]. The gene discussed is NOS2; the disease is kidney disorder.